Comment on: 'The role of thalidomide in dermatology'
- PMID: 34997621
- DOI: 10.1111/ced.15096
Comment on: 'The role of thalidomide in dermatology'
Comment on
-
The role of thalidomide in dermatology.Clin Exp Dermatol. 2022 Apr;47(4):667-674. doi: 10.1111/ced.15019. Epub 2021 Dec 19. Clin Exp Dermatol. 2022. PMID: 34779533 Review.
References
-
- Hussain K, Patel P, Roberts N. The role of thalidomide in dermatology. Clin Exp Dermatol 2021. https://doi.org/10.1111/ced.15019.
-
- Sharma NL, Sharma VC, Mahajan VK et al. Thalidomide: an experience in therapeutic outcome and adverse reactions. J Dermatolog Treat 2007; 18: 335-40.
-
- Khalil A, Kamar A, Nemer G. Thalidomide-revisited: are COVID-19 patients going to be the latest victims of yet another theoretical drug-repurposing? Front Immunol 2020; 11: 1248.
-
- Chasset F, Tounsi T, Cesbron E et al. Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: a systematic review and meta-analysis. J Am Acad Dermatol 2018; 78: 342-50.e4.
-
- Niesvizky R, Martínez-Baños D, Jalbrzikowski J et al. Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. Leuk Lymphoma 2007; 48: 2330-7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources